I recently read a letter published in your paper in which a concerned citizen called on the government and insurance companies to negotiate better drug prices, citing the high cost of medication in ...

Pharmacy chain BENU is warning that a steep price increase for the blood thinner Eliquis is threatening patient access to ...

Biotech giant Bristol-Myers Squibb Company (BMY) is scheduled to report second-quarter 2025 results on July 31, before market ...

Excessive markups don’t benefit patients – they simply enrich middlemen, writes the co-chair of the We Work For Health Coalition.

UT Dell Medical School study helps solve question of when to start blood thinners after a stroke in someone with AFib.

AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

On CNBC's "Mad Money Lightning Round," Jim Cramer praised home improvement retailer Lowe's Companies and CrowdStrike Holdings ...

As the relentless march of aging make my knee and shoulder sore, as my lenses cloud and the upper range of my hearing ...